0.825
price up icon1.85%   0.015
after-market 시간 외 거래: .83 0.005 +0.61%
loading
전일 마감가:
$0.81
열려 있는:
$0.86
하루 거래량:
20,186
Relative Volume:
0.18
시가총액:
$4.30M
수익:
-
순이익/손실:
$-736.70K
주가수익비율:
-82.50
EPS:
-0.01
순현금흐름:
$-4.14M
1주 성능:
+2.56%
1개월 성능:
+8.55%
6개월 성능:
-18.32%
1년 성능:
-66.19%
1일 변동 폭
Value
$0.81
$0.86
1주일 범위
Value
$0.767
$0.86
52주 변동 폭
Value
$0.6608
$2.59

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Name
명칭
Xortx Therapeutics Inc
Name
전화
-
Name
주소
-
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
XRTX's Discussions on Twitter

XRTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XRTX
Xortx Therapeutics Inc
0.825 4.22M 0 -736.70K -4.14M -0.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스

pulisher
04:44 AM

how to use a screener to detect xortx therapeutics inc. breakoutsJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser

04:44 AM
pulisher
Sep 05, 2025

Published on: 2025-09-05 18:19:26 - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Can XORTX Therapeutics Inc. expand into new marketsJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

What are XORTX Therapeutics Inc.’s growth leversJuly 2025 Movers & Growth Focused Stock Reports - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Can XORTX Therapeutics Inc. scale operations efficientlyJuly 2025 Analyst Calls & Fast Gain Swing Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is XORTX Therapeutics Inc. stock a good dividend stockJuly 2025 Sentiment & Consistent Income Trade Ideas - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Can XORTX Therapeutics Inc. continue delivering strong returns2025 Key Highlights & Advanced Technical Analysis Signals - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Visual trend scoring systems applied to XORTX Therapeutics Inc.Earnings Beat & Expert Curated Trade Setups - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Combining machine learning predictions for XORTX Therapeutics Inc.CPI Data & Fast Gaining Stock Strategy Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to monitor XORTX Therapeutics Inc. with trend dashboards2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

XORTX Therapeutics to Host Investor Webinar on Strategic Developments - TipRanks

Sep 04, 2025
pulisher
Sep 04, 2025

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10 - GlobeNewswire

Sep 04, 2025
pulisher
Sep 04, 2025

$700M Annual Market: XORTX Therapeutics Advancing Late-Stage Gout Drug XORLO Toward 2026 FDA Filing - Stock Titan

Sep 04, 2025
pulisher
Sep 04, 2025

When is the best time to exit XORTX Therapeutics Inc.Short Setup & Low Drawdown Momentum Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Tools to monitor XORTX Therapeutics Inc. recovery probability2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Reversal indicators forming on XORTX Therapeutics Inc. stockJuly 2025 Institutional & Growth Focused Entry Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does XORTX Therapeutics Inc. fit your quant trading modelMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is this a good reentry point in XORTX Therapeutics Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

XORTX Advances Gout Treatment Program with IND Preparation - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

XORTX's Path to NDA Filing for XORLO™: A Strategic Milestone in Gout Therapy Innovation - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Major FDA Filing Milestone: XORTX's Novel Gout Treatment XORLO Advances Toward Clinical Trials - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for XORTX Therapeutics Inc. explainedEarnings Growth Summary & Stepwise Swing Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will XORTX Therapeutics Inc. stock go up soon2025 Trade Ideas & High Win Rate Trade Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will XORTX Therapeutics Inc. outperform during market ralliesQuarterly Risk Review & Low Risk Profit Maximizing Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 02, 2025

Using data models to predict XORTX Therapeutics Inc. stock movement2025 Support & Resistance & Growth Focused Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is XORTX Therapeutics Inc. gaining market shareJuly 2025 Sentiment & High Conviction Investment Ideas - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Using Ichimoku Cloud for XORTX Therapeutics Inc. technicalsWeekly Trade Recap & Fast Gain Swing Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is XORTX Therapeutics Inc. attractive for institutional investors2025 Valuation Update & Consistent Growth Stock Picks - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Can XORTX Therapeutics Inc. expand its profit marginsEarnings Risk Report & Daily Profit Focused Stock Screening - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

What are XORTX Therapeutics Inc.’s earnings expectationsWeekly Gains Report & Risk Managed Investment Strategies - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

What are XORTX Therapeutics Inc.’s recent SEC filings showingMarket Sentiment Summary & Daily Risk Controlled Trade Plans - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Live market analysis of XORTX Therapeutics Inc.2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs - MSN

Sep 02, 2025
pulisher
Sep 01, 2025

Best data tools to analyze XORTX Therapeutics Inc. stockWeekly Risk Report & Risk Controlled Daily Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Institutional scanner results for XORTX Therapeutics Inc.Fed Meeting & AI Powered Buy and Sell Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Using R and stats models for XORTX Therapeutics Inc. forecastingProduct Launch & Short-Term Trading Opportunity Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Is XORTX Therapeutics Inc. still worth holding after the dip2025 Winners & Losers & Low Risk Investment Opportunities - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

XORTX Therapeutics Inc. stock daily chart insightsDollar Strength & Weekly Top Performers Watchlists - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to use a screener to detect XORTX Therapeutics Inc. breakoutsSwing Trade & Expert Curated Trade Setups - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What indicators show strength in XORTX Therapeutics Inc.Weekly Market Report & Safe Capital Growth Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is XORTX Therapeutics Inc. stock good for income investorsForecast Cut & AI Enhanced Trading Signals - 한국정경신문

Aug 31, 2025
pulisher
Aug 31, 2025

Is XORTX Therapeutics Inc. likely to announce a buyback2025 Fundamental Recap & Low Risk Entry Point Guides - 한국정경신문

Aug 31, 2025

Xortx Therapeutics Inc (XRTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):